Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 Pandemic
Narek Shaverdian, Annemarie F Shepherd, Andreas Rimner, Abraham J Wu, Charles B Simone 2nd, Daphna Y Gelblum, Daniel R Gomez, Narek Shaverdian, Annemarie F Shepherd, Andreas Rimner, Abraham J Wu, Charles B Simone 2nd, Daphna Y Gelblum, Daniel R Gomez
Abstract
Purpose: Patients with cancer are at high risk for mortality from coronavirus disease 2019 (COVID-19). Radiation pneumonitis (RP) is a common toxicity of thoracic radiation therapy with clinical and imaging features that overlap with those of COVID-19; however, RP is treated with high-dose corticosteroids, which may exacerbate COVID-19-associated lung injury. We reviewed patients who presented with symptoms of RP during the intensification of a regional COVID-19 epidemic to report on their clinical course and COVID-19 testing results.
Methods and materials: The clinical course and chest computed tomography (CT) imaging findings of consecutive patients who presented with symptoms of RP in March 2020 were reviewed. The first regional COVID-19 case was diagnosed on March 1, 2020. All patients underwent COVID-19 qualitative RNA testing.
Results: Four patients with clinical suspicion for RP were assessed. Three out of 4 patients tested positive for COVID-19. All patients presented with symptoms of cough and dyspnea. Two patients had a fever, of whom only 1 tested positive for COVID-19. Two patients started on an empirical high-dose corticosteroid taper for presumed RP, but both had clinical deterioration and ultimately tested positive for COVID-19 and required hospitalization. Chest CT findings in patients suspected of RP but ultimately diagnosed with COVID-19 showed ground-glass opacities mostly pronounced outside the radiation field.
Conclusions: As this pandemic continues, patients with symptoms of RP require diagnostic attention. We recommend that patients suspected of RP be tested for COVID-19 before starting empirical corticosteroids and for careful attention to be paid to chest CT imaging to prevent potential exacerbation of COVID-19 in these high-risk patients.
© 2020 The Author(s).
Figures
References
- Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335–337.
- Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China [epub ahead of print] JAMA Oncol. 2020 doi: 10.1001/jamaoncol.2020.0980. Accessed May 13, 2020.
- Rodrigues G., Lock M., D'Souza D., Yu E., Van Dyk J. Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review. Radiother Oncol. 2004;71:127–138.
- Bledsoe T.J., Nath S.K., Decker R.H. Radiation pneumonitis. Clin Chest Med. 2017;38:201–208.
- Guan W.-j., Ni Z.-y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382:1708–1720.
- Li Y., Xia L. Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. Am J Roentgenol. 2020;4:1–7.
- Bernheim A., Mei X., Huang M. Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection [epub ahead of print] Radiology. 2020 doi: 10.1148/radiol.2020200463. Accessed May 13, 2020.
- Ai T., Yang Z., Hou H. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases [epub ahead of print] Radiology. 2020 doi: 10.1148/radiol.2020200642. Accessed May 13, 2020.
- Choi Y.W., Munden R.F., Erasmus J.J. Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis. Radiographics. 2004;24:985–997. discussion 98.
- West C.P., Montori V.M., Sampathkumar P. COVID-19 testing: The threat of false-negative results [epub ahead of print] Mayo Clinic Proc. 2020 doi: 10.1016/j.mayocp.2020.04.004. Accessed May 13, 2020.
- Wang W., Xu Y., Gao R. Detection of SARS-CoV-2 in different types of clinical specimens [epub ahead of print] JAMA. 2020 doi: 10.1001/jama.2020.3786. Accessed May 13, 2020.
- Russell C.D., Millar J.E., Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475.
- Arabi Y.M., Mandourah Y., Al-Hameed F. Corticosteroid therapy for critically Ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2018;197:757–767.
Source: PubMed